Bruker’s BRKR strong growth reflects its fundamental commitment to innovate high-value solutions and ongoing portfolio ...

A new PET radiotracer can effectively visualize Nectin-4, an emerging biomarker found in triple-negative breast cancer (TNBC) ...

Fluorescence imaging is the visualization of fluorescent dyes or proteins as labels for molecular processes or structures. It enables a wide range of experimental observations including the ...

Bruker Corporation BRKR recently launched the new X4 POSEIDON, a high-performance 3D X-ray microscope (XRM) using ...

as well as optical imaging and, evaluate these biomarkers in pre-clinical cancer models. Significant efforts are directed towards validating biomarkers for early prediction of treatment response, with ...

Guillaume Tetard, Bruker Biospin Vice President for Optical and mCT Preclinical Imaging, emphasized the system's unmatched image quality in its category, making it ideal for life-science applications, ...

Guillaume Tetard, Bruker Biospin Vice President for Optical and mCT Preclinical Imaging, added: "The X4 POSEIDON is a cutting-edge XRM system with unmatched image quality in its category for ...

Guillaume Tetard, Bruker Biospin Vice President for Optical and mCT Preclinical Imaging, emphasized the system's unmatched image quality in its category, making it ideal for life-science ...

A Mass General Brigham-led study in preclinical models suggests that a ... A Brigham Research Institute Pilot imaging microgrant was received. Mass General Brigham is an integrated academic ...

In its fourth quarter 2024 investor letter, The London Company SMID Cap Strategy emphasized stocks such as Bruker Corporation (NASDAQ:BRKR). Bruker Corporation (NASDAQ:BRKR) focuses on developing ...